Alexza Pharmaceuticals
2091 Stierlin Court
Mountain View
California
94043
United States
Tel: 650-944-7000
Fax: 650-944-7999
Website: http://www.alexza.com/
Email: info@alexza.com
262 articles about Alexza Pharmaceuticals
-
Alexza Pharmaceuticals, Inc. Announces The Launch Of ADASUVE® (Inhalation Powder, loxapine) In Guatemala
8/8/2014
-
Alexza Pharmaceuticals, Inc. Provides Pipeline Update
8/1/2014
-
Alexza Pharmaceuticals, Inc. Announces Participation In Upcoming Investor Conferences
7/30/2014
-
Alexza Pharmaceuticals, Inc. To Report 2014 Second Quarter Financial Results On Thursday, August 7, 2014
7/18/2014
-
Alexza Pharmaceuticals, Inc. Announces The Promotion Of Edwin S. Kamemoto, Ph.D. To Senior Vice President, Regulatory Affairs
7/1/2014
-
Alexza Pharmaceuticals, Inc. Reports 2014 First Quarter Financial Results
5/6/2014
-
Alexza Pharmaceuticals, Inc. Announces The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In The Nordic Countries
5/1/2014
-
Winston R. Brown, Jr. Joins Alexza Pharmaceuticals, Inc. As Vice President, Quality
4/17/2014
-
Alexza Pharmaceuticals, Inc. To Report 2014 First Quarter Financial Results On Monday, May 5, 2014
4/17/2014
-
Bay Area's Alexza Pharmaceuticals, Inc. Reels In $45 Million Private Placement
3/19/2014
-
Alexza Pharmaceuticals, Inc. And Ferrer Internacional Announce The Launch Of ADASUVE® (Inhalation Powder, Loxapine) In Romania
3/14/2014
-
Alexza Pharmaceuticals, Inc. Reports Fourth Quarter And Year End 2013 Financial Results
3/7/2014
-
Alexza Pharmaceuticals, Inc. Announces The U.S. Commercial Launch Of ADASUVE® By Teva Pharmaceutical Industries Limited
3/3/2014
-
Robert A. Lippe Joins Alexza Pharmaceuticals, Inc. As Executive Vice President, Operations And Chief Operations Officer
2/25/2014
-
Alexza Pharmaceuticals, Inc.' Corporate Presentation To Be Webcast From Two Upcoming March Investor Conferences
2/21/2014
-
Alexza Pharmaceuticals, Inc. To Report 2013 Year-End Financial Results On Thursday, March 6, 2014
2/13/2014
-
Alexza Pharmaceuticals, Inc. Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment
1/23/2014
-
Alexza Pharmaceuticals, Inc. To Present At The 25th Annual Piper Jaffray Healthcare Conference
11/22/2013
-
Alexza Pharmaceuticals, Inc. Reports 2013 Third Quarter Financial Results
11/7/2013
-
Alexza Pharmaceuticals, Inc. and Grupo Ferrer Internacional S.A. Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria
10/24/2013